Stock Scorecard
Stock Summary for CVS Health Corp (CVS) - $65.62 as of 7/10/2025 9:15:43 PM EST
Total Score
15 out of 30
Safety Score
66 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for CVS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CVS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CVS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CVS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CVS (66 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 2 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CVS
Financial Details for CVS
Company Overview |
|
|---|---|
| Ticker | CVS |
| Company Name | CVS Health Corp |
| Country | USA |
| Description | CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island. |
| Sector Name | TRADE & SERVICES |
| Industry Name | RETAIL-DRUG STORES AND PROPRIETARY STORES |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 7/31/2025 |
Stock Price History |
|
| Last Day Price | 65.62 |
| Price 4 Years Ago | 91.70 |
| Last Day Price Updated | 7/10/2025 9:15:43 PM EST |
| Last Day Volume | 6,324,351 |
| Average Daily Volume | 7,060,482 |
| 52-Week High | 72.51 |
| 52-Week Low | 42.57 |
| Last Price to 52 Week Low | 54.15% |
Valuation Measures |
|
| Trailing PE | 15.91 |
| Industry PE | 181.96 |
| Sector PE | 50.60 |
| 5-Year Average PE | 13.57 |
| Free Cash Flow Ratio | 8.23 |
| Industry Free Cash Flow Ratio | 4.92 |
| Sector Free Cash Flow Ratio | 62.99 |
| Current Ratio Most Recent Quarter | 0.82 |
| Total Cash Per Share | 7.97 |
| Book Value Per Share Most Recent Quarter | 60.96 |
| Price to Book Ratio | 1.10 |
| Industry Price to Book Ratio | 0.91 |
| Sector Price to Book Ratio | 10.94 |
| Price to Sales Ratio Twelve Trailing Months | 0.23 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.26 |
| Sector Price to Sales Ratio Twelve Trailing Months | 2.29 |
| Analyst Buy Ratings | 13 |
| Analyst Strong Buy Ratings | 8 |
Share Statistics |
|
| Total Shares Outstanding | 1,265,020,000 |
| Market Capitalization | 83,010,612,400 |
| Institutional Ownership | 87.36% |
Dividends |
|
| Ex-Dividend Date | 7/22/2025 |
| Previous Dividend Amount | 0.6650 |
| Current Dividend Amount | 0.6650 |
| Total Years Dividend Increasing | 3 |
| Trailing Annual Dividend Rate | 2.66 |
| Trailing Annual Dividend Yield | 3.99% |
| Forward Annual Dividend Rate | 2.66 |
| Forward Annual Dividend Yield | 3.99% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 6.06% |
| 5-Year Average Dividend Yield | 3.53% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 7.39% |
| All-Time Dividend Growth Rate Percentage | 7.12% |
| Dividend Payout Ratio | 63.48% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 60.20% |
| Annual Earnings Growth | -44.70% |
| Reported EPS 12 Trailing Months | 4.19 |
| Reported EPS Past Year | 2.25 |
| Reported EPS Prior Year | 5.42 |
| Net Income Twelve Trailing Months | 5,280,000,000 |
| Net Income Past Year | 4,614,000,000 |
| Net Income Prior Year | 8,344,000,000 |
| Quarterly Revenue Growth YOY | 6.90% |
| 5-Year Revenue Growth | 7.74% |
| Operating Margin Twelve Trailing Months | 3.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 10,076,000,000 |
| Total Cash Past Year | 8,586,000,000 |
| Total Cash Prior Year | 8,196,000,000 |
| Net Cash Position Most Recent Quarter | -48,964,000,000 |
| Net Cash Position Past Year | -51,941,000,000 |
| Long Term Debt Past Year | 60,527,000,000 |
| Long Term Debt Prior Year | 58,638,000,000 |
| Total Debt Most Recent Quarter | 59,040,000,000 |
| Equity to Debt Ratio Past Year | 0.56 |
| Equity to Debt Ratio Most Recent Quarter | 0.57 |
| Total Stockholder Equity Past Year | 75,560,000,000 |
| Total Stockholder Equity Prior Year | 76,461,000,000 |
| Total Stockholder Equity Most Recent Quarter | 76,929,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 5,941,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 4.70 |
| Free Cash Flow Past Year | 6,326,000,000 |
| Free Cash Flow Prior Year | 10,395,000,000 |
Options |
|
| Put/Call Ratio | 0.21 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.96 |
| MACD Signal | 0.92 |
| 20-Day Bollinger Lower Band | 61.69 |
| 20-Day Bollinger Middle Band | 65.72 |
| 20-Day Bollinger Upper Band | 69.75 |
| Beta | 0.56 |
| RSI | 55.07 |
| 50-Day SMA | 59.13 |
| 150-Day SMA | 67.14 |
| 200-Day SMA | 72.10 |
System |
|
| Modified | 7/8/2025 9:46:00 PM EST |